• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

环状CRISPR编辑人类多能干细胞用于疾病建模。

Circular CRISPR Edits Human Pluripotent Stem Cells for Disease Modeling.

作者信息

Bao Weihao, Fan Wei, Zhang Yongshuai, Lan Feng, Ma Shuhong

机构信息

State Key Laboratory of Cardiovascular Disease, Key Laboratory of Pluripotent Stem Cells in Cardiac Repair and Regeneration, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100037, China.

Department of Cardiovascular Surgery, Metabolic Vascular Diseases Key Laboratory of Sichuan Province, Key Laboratory of Cardiovascular Remodeling and Dysfunction, The Affiliated Hospital, Southwest Medical University, Luzhou, 646000, Sichuan, P.R. China.

出版信息

Stem Cell Rev Rep. 2025 Apr 7. doi: 10.1007/s12015-025-10871-2.

DOI:10.1007/s12015-025-10871-2
PMID:40192983
Abstract

The CRISPR system has been widely used for human pluripotent stem cell (hPSC) disease modeling. Circular RNA can effectively reduce RNA immunogenicity and improve RNA stability, thus contributing to in vivo DNA editing. In this study, we briefly describe the process of circularizing guide RNA and CRISPR base editing elements and using them to establish stem cell disease models. Our work provides step-by-step guidance for constructing gene point editing cell lines, offering a reliable, low-immunogenic alternative for disease modeling and therapeutic research.

摘要

CRISPR系统已被广泛应用于人类多能干细胞(hPSC)疾病建模。环状RNA可以有效降低RNA免疫原性并提高RNA稳定性,从而有助于体内DNA编辑。在本研究中,我们简要描述了环状引导RNA和CRISPR碱基编辑元件的过程,并使用它们建立干细胞疾病模型。我们的工作为构建基因点编辑细胞系提供了循序渐进的指导,为疾病建模和治疗研究提供了一种可靠的、低免疫原性的替代方法。

相似文献

1
Circular CRISPR Edits Human Pluripotent Stem Cells for Disease Modeling.环状CRISPR编辑人类多能干细胞用于疾病建模。
Stem Cell Rev Rep. 2025 Apr 7. doi: 10.1007/s12015-025-10871-2.
2
Leveraging CRISPR activation for rapid assessment of gene editing products in human pluripotent stem cells.利用CRISPR激活技术快速评估人类多能干细胞中的基因编辑产物。
Stem Cell Reports. 2025 Jun 10;20(6):102499. doi: 10.1016/j.stemcr.2025.102499. Epub 2025 May 8.
3
CRISPRoffT: comprehensive database of CRISPR/Cas off-targets.CRISPRoffT:CRISPR/Cas脱靶效应的综合数据库。
Nucleic Acids Res. 2025 Jan 6;53(D1):D914-D924. doi: 10.1093/nar/gkae1025.
4
A comprehensive all-in-one CRISPR toolbox for large-scale screens in plants.用于植物大规模筛选的综合性一体化CRISPR工具箱。
Plant Cell. 2025 Apr 2;37(4). doi: 10.1093/plcell/koaf081.
5
CRISPR GENome and epigenome engineering improves loss-of-function genetic-screening approaches.CRISPR基因组和表观基因组工程改进了功能丧失型基因筛选方法。
Cell Rep Methods. 2025 Jun 16;5(6):101078. doi: 10.1016/j.crmeth.2025.101078. Epub 2025 Jun 10.
6
Exploring the synergy of CRISPR and microphysiological systems.探索CRISPR与微生理系统的协同作用。
ALTEX. 2025 May 9. doi: 10.14573/altex.2403251.
7
Focused ultrasound and microbubble-mediated delivery of CRISPR-Cas9 ribonucleoprotein to human induced pluripotent stem cells.聚焦超声与微泡介导的CRISPR-Cas9核糖核蛋白向人诱导多能干细胞的递送
Mol Ther. 2025 Mar 5;33(3):986-996. doi: 10.1016/j.ymthe.2025.01.013. Epub 2025 Jan 10.
8
Specific modulation of CRISPR transcriptional activators through RNA-sensing guide RNAs in mammalian cells and zebrafish embryos.通过在哺乳动物细胞和斑马鱼胚胎中进行RNA感应引导RNA对CRISPR转录激活因子进行特异性调控。
Elife. 2025 Jul 29;12:RP87722. doi: 10.7554/eLife.87722.
9
Cell-Penetrating Peptides and CRISPR-Cas9: A Combined Strategy for Human Genetic Disease Therapy.细胞穿透肽与 CRISPR-Cas9:用于人类遗传疾病治疗的联合策略。
Hum Gene Ther. 2024 Oct;35(19-20):781-797. doi: 10.1089/hum.2024.020.
10
Higher resolution pooled genome-wide CRISPR knockout screening in Drosophila cells using integration and anti-CRISPR (IntAC).利用整合和抗CRISPR(IntAC)在果蝇细胞中进行更高分辨率的全基因组CRISPR敲除筛选。
Nat Commun. 2025 Jul 15;16(1):6498. doi: 10.1038/s41467-025-61692-3.

本文引用的文献

1
Next-Gen Therapeutics: Pioneering Drug Discovery with iPSCs, Genomics, AI, and Clinical Trials in a Dish.下一代疗法:利用诱导多能干细胞、基因组学、人工智能以及体外临床试验开拓药物研发。
Annu Rev Pharmacol Toxicol. 2025 Jan;65(1):71-90. doi: 10.1146/annurev-pharmtox-022724-095035. Epub 2024 Dec 17.
2
Crispr-Based Editing of Human Pluripotent Stem Cells for Disease Modeling.基于 Crispr 的人类多能干细胞编辑用于疾病建模。
Stem Cell Rev Rep. 2024 Jul;20(5):1151-1161. doi: 10.1007/s12015-024-10713-7. Epub 2024 Apr 2.
3
Progress and Prospects of Gene Editing in Pluripotent Stem Cells.
多能干细胞基因编辑的进展与展望
Biomedicines. 2023 Aug 1;11(8):2168. doi: 10.3390/biomedicines11082168.
4
CRISPR and cardiovascular diseases.CRISPR与心血管疾病。
Cardiovasc Res. 2023 Mar 17;119(1):79-93. doi: 10.1093/cvr/cvac048.
5
Human-induced pluripotent stem cells in cardiovascular research: current approaches in cardiac differentiation, maturation strategies, and scalable production.人诱导多能干细胞在心血管研究中的应用:心脏分化的当前方法、成熟策略和可扩展生产。
Cardiovasc Res. 2022 Jan 7;118(1):20-36. doi: 10.1093/cvr/cvab115.
6
Engineering circular RNA for potent and stable translation in eukaryotic cells.工程化环状 RNA 以在真核细胞中实现高效稳定的翻译。
Nat Commun. 2018 Jul 6;9(1):2629. doi: 10.1038/s41467-018-05096-6.
7
Developmental changes in cardiomyocytes differentiated from human embryonic stem cells: a molecular and electrophysiological approach.人胚胎干细胞分化的心肌细胞的发育变化:分子与电生理方法
Stem Cells. 2007 May;25(5):1136-44. doi: 10.1634/stemcells.2006-0466. Epub 2007 Jan 25.